Open access · CC-BY
via OpenAlex
Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
Yi Zhu, Tamar Tchkonia, Heike Fuhrmann‐Stroissnigg, Haiming Dai, Yuanyuan Ling, Michael B. Stout, Tamar Pirtskhalava, Nino Giorgadze, Kurt O. Johnson, Cory B. Giles, Jonathan D. Wren, Laura J. Niedernhofer, Paul D. Robbins, James L. Kirkland
Aging Cell · 2015 · ▲ 1,142 citations
Abstract
Clearing senescent cells extends healthspan(definition) in mice. Using a hypothesis-driven bioinformatics-based approach, we recently identified pro-survival pathways in human senescent cells that contribute to their resistance to apoptosis. This led to identification of dasatinib (D) and quercetin (Q) as senolytics(definition), agents that target some of these pathways and induce apoptosis preferentially in senescent cells. Among other pro-survival regulators identified was Bcl-xl. Here, we tested whether the Bcl-2 family inhibitors, navitoclax (N) and TW-37 (T), are senolytic. Like D and Q, N is senolytic in some, but not all types of senescent cells: N reduced viability of senescent human umbilical vein epithelial cells (HUVECs), IMR90 human lung fibroblasts, and murine embryonic fibroblasts (MEFs), but not human primary preadipocytes, consistent with our previous finding that Bcl-xl siRNA is senolytic in HUVECs, but not preadipocytes. In contrast, T had little senolytic activity. N targets Bcl-2, Bcl-xl, and Bcl-w, while T targets Bcl-2, Bcl-xl, and Mcl-1. The combination of Bcl-2, Bcl-xl, and Bcl-w siRNAs was senolytic in HUVECs and IMR90 cells, while combination of Bcl-2, Bcl-xl, and Mcl-1 siRNAs was not. Susceptibility to N correlated with patterns of Bcl-2 family member proteins in different types of human senescent cells, as has been found in predicting response of cancers to N. Thus, N is senolytic and acts in a potentially predictable cell type-restricted manner. The hypothesis-driven, bioinformatics-based approach we used to discover that dasatinib (D) and quercetin (Q) are senolytic can be extended to increase the repertoire of senolytic drugs, including additional cell type-specific senolytic agents.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.12445
- Canonical
- link ↗
- Fetched
- 2026-09-15 MST
Cite this
APA
Zhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H., Ling, Y., Stout, M.B., Pirtskhalava, T., Giorgadze, N., Johnson, K.O., Giles, C.B., Wren, J.D., Niedernhofer, L.J., Robbins, P.D., & Kirkland, J.L. (2015). Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors. <em>Aging Cell</em>. https://doi.org/10.1111/acel.12445
Vancouver
Zhu Y, Tchkonia T, Fuhrmann‐Stroissnigg H, Dai H, Ling Y, Stout MB, et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors. Aging Cell. 2015. doi:10.1111/acel.12445.
BibTeX
@article{yi2015Identi,
title = {Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors},
author = {Yi Zhu and Tamar Tchkonia and Heike Fuhrmann‐Stroissnigg and Haiming Dai and Yuanyuan Ling and Michael B. Stout and Tamar Pirtskhalava and Nino Giorgadze and Kurt O. Johnson and Cory B. Giles and Jonathan D. Wren and Laura J. Niedernhofer and Paul D. Robbins and James L. Kirkland},
journal = {Aging Cell},
year = {2015},
doi = {10.1111/acel.12445},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging 2017
Open access · CC-BY
New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463
Aging Cell 2026
Open access · CC-BY
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan
Aging cell 2026
Citation only
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan.
Pharmaceuticals 2024
Open access · CC-BY
Researching New Drug Combinations with Senolytic Activity Using Senescent Human Lung Fibroblasts MRC-5 Cell Line
Aging 2020
Preprint · CC-BY
Identification of SYK inhibitor, R406 as a novel senolytic agent
Nature Communications 2017
Open access · CC-BY